Skip to main content
. 2017 Sep 4;8:433. doi: 10.3389/fneur.2017.00433

Table 2.

MRI studies evaluating the relationship between spinal cord atrophy and disability.

Reference Patients (n) MRI measure of neurodegeneration [acquisition/quantification methods] Measure of disability Results
CROSS-SECTIONAL STUDIES
Rocca et al. (95) 335 with MS
  • Cervical cord CSA (C2 to C5)

[3D T1w/active surface method]
  • EDSS

  • Cord CSA correlated with EDSS in patients with RRMS (r = −0.30; p = 0.001), SPMS (r = −0.34; p = 0.001), and PPMS (r = −0.27; p = 0.01), but not in patients with CIS or benign MS

Biberacher et al. (91) 267 with CIS or RRMS
  • Upper cervical cord CSA at C2/C3

[3D T1w/FSL software]
  • EDSS

  • Cord CSA correlated with EDSS (r = −0.131; p = 0.044)

Weier et al. (102) 202 with MS
  • Whole spinal cord atrophy

[T2w/visual assessment]
  • EDSS

  • Weak correlation between cord atrophy and EDSS scores (r = 0.30)

Daams et al. (92) 196 with MS
  • Upper cervical cord CSA

[3D T1w/semi-automated method]
  • EDSS

  • T25FW

  • 9HPT

  • Cord Functional Score

  • Cord area was independently associated with EDSS (r = −0.296; p < 0.001), T25FW (r = 0.240; p = 0.001), and 9HPT (r = −0.206; p = 0.005)

Bernitsas et al. (90) 150 with MS
  • Cervical cord CSA (C2)

[3D T1w/Losseff semi-automated method (104)]
  • EDSS

  • Significant correlation between CSA-C2 and EDSS (r = −0.75; p < 0.0001)

  • Multivariable regression showed that CSA-C2 was a significant predictor of disability independent of disease duration and phenotype (p < 0.0001)

Oh et al. (94) 133 with MS
  • C3–C4 cord volume

[3D T1w/fully automated segmentation protocol (105)]
  • EDSS

  • MSFC

  • Hip flexion strength

  • Vibration sensation threshold

  • Correlations between clinical measures (EDSS: r = −0.20, p = 0.02; MSFC: r = 0.16, p = 0.06; hip flexion strength: r = 0.35, p = 0.0001; vibration threshold: r = −0.19, p = 0.03) and cord volume

Yiannakas et al. (99) 120 with MS (40 in longitudinal subgroup; 1-year follow-up)
  • Cervical cord CSA (two segments: C2/C3 and C2/C5)

[3D T1w/Propseg vs semi-automated active surface method]
  • EDSS

  • MSFC

  • T25FW

  • 9HPT

  • ASIA motor and sensory scores

  • Baseline CSA was significantly associated with baseline clinical variables (both segments) (p < 0.001 for all)

  • CSA measures at 1 year were significantly associated with ASIA motor and sensory scores only (p = 0.048 to p = 0.001)

  • Baseline CSA for both segments predicted ASIA motor scores at 1 year (p ≤ 0.003)

Schlaeger et al. (96) 113 with MS
  • Spinal cord WM area (C2/C3)

  • Spinal cord GM area (C2/C3)

  • Upper cervical cord CSA (C2/C3)

[2D PSIR/Active surface method]
  • EDSS

  • T25FW

  • 9HPT

  • GM, WM, and cord CSA significantly correlated with EDSS (r = −0.60, −0.32, and −0.42, respectively; all p ≤ 0.001) and T25FW (r = −0.50, −0.28, and −0.36, respectively; p < 0.001, p = 0.004 and p < 0.001, respectively)

  • GM area (r = −0.37) and cord CSA (r = −0.22) significantly correlated with 9HPT (p < 0.001 and p = 0.024, respectively)

  • GM area was the strongest correlate of disability in multivariate models

Rocca et al. (106) 77 with MS
  • Regional cervical cord atrophy (voxel-based)

[3D T1w/voxel-based analysis, active surface method]
  • EDSS

  • FSS

  • SPMS: cord atrophy at C1/C2 correlated with pyramidal FSS (r = −0.91; p < 0.001)

  • PPMS: cord atrophy at C1/C2 correlated with EDSS (r = −0.68) and pyramidal FSS (r = −0.89) (p < 0.001)

  • No correlation between regional cord atrophy and clinical variables for other MS phenotypes

Valsasina et al. (98) 71 with RRMS or SPMS
  • Regional cervical cord atrophy

[3D T1w/voxel-based analysis, active surface method]
  • EDSS

  • Regional cervical cord atrophy was correlated with clinical disability (r = −0.46 to −0.57; p < 0.001)

Benedetti et al. (100) 68 with benign MS or SPMS
  • Cervical cord CSA

[3D T1w/semi-automated method of Losseff (104)]
  • EDSS

  • Cord CSA was an independent predictor of EDSS (p = 0.001)

Horsfield et al. (93) 40 with RRMS or SPMS
  • Cervical cord CSA (C2 and C2–C5)

[3D T1w/semiautomatic active surface vs Losseff method (104)]
  • EDSS

  • Ambulation index

  • Strong correlations between the EDSS (C2: r = −0.51; C2–C5: r = −0.59) and ambulation index (C2: r = −0.58; C2–C5: r = −0.648) and CSA (p < 0.001)

Healy et al. (101) 34 with MS
  • C2–3 volume

  • Cervical cord volume

  • Thoracic cord volume

  • Whole cord volume

[T2-weighted sequence/JIM software]
  • EDSS

  • C2–3 volume and cervical cord volume correlated with EDSS score (p < 0.05)

Song et al. (97) 29 with MS
  • Upper cervical cord CSA

[3D T1w and T2w/semi-automated software (107)]
  • EDSS

  • Stronger correlation between EDSS and normalized measurement of cord area vs absolute measurement [r = −0.84 (p < 0.01) vs r = −0.46 (p < 0.05)]

Blamire et al. (103) 11
  • Spinal cord CSA (C2–C5)

[T1w/Jim software]
  • EDSS

  • 9PHT

  • T25FW

  • No correlation between cord atrophy and measures of disability

LONGITUDINAL STUDIES
Valsasina et al. (89) 35 with MS (mean follow-up, 2.3 years)
  • Cervical cord CSA

[3D T1w/active surface method vs Losseff method]
  • EDSS

  • At baseline, there was a significant correlation between EDSS and both methods used to measure CSA (AS method: r = −0.59; p < 0.001; Losseff method: r = −0.40; p = 0.01)

  • At follow-up, AS cord CSA (but not CSA evaluated using the Losseff method) correlated with EDSS (r = −0.50; p = 0.002)

Studies within each subsection are ordered according to size of patient population.

9HPT, 9-hole peg test; AS, active surface; ASIA, American Spinal Injury Association; CIS, clinically isolated syndrome; CSA, cross-sectional area; EDSS, Expanded Disability Status Scale; FSS, Functional Scale Score; GM, grey matter; MRI, magnetic resonance imaging; MS, multiple sclerosis; MSFC, Multiple Sclerosis Functional Composite; RRMS, relapsing-remitting multiple sclerosis; SPMS, secondary progressive multiple sclerosis; T1w, T1-weighted; T2w, T2-weighted; T25FW, timed 25-foot walk; WM, white matter.